Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

PF-4942847

SKU: orb2814791

Description

PF-4942847 is a novel, orally bioavailable Hsp90 inhibitor under investigation for triple-negative breast cancer (TNBC) due to its synergistic disruption of multiple oncogenic pathways. Its mechanism, demonstrated in vitro and in vivo, includes inducing AKT degradation in peripheral blood lymphocytes, a potential pharmacodynamic biomarker for clinical trials.

Images & Validation

Key Properties

CAS Number1046859-34-0
MW516.3
FormulaC20H18Cl2F3N7O2
SMILESO=C(NCC(F)(F)F)N1CC=2N=C(N=C(C=3C(Cl)=CC(Cl)=CC3OCCN4N=CC=C4)C2C1)N

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

25 mg
$ 2,010.00
50 mg
$ 2,620.00
100 mg
$ 3,440.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry